Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottle
See all recalls from Hikma Pharmaceuticals USA INC. →Recalled Product
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
Hazard / Issue
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #: 3047, Exp Date July 2027.
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for Abirtega (abiraterone acetate) USP, →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime